Is Inflammation the Answer? A Potential Future Treatment for Age-Related Macular Degeneration

Описание к видео Is Inflammation the Answer? A Potential Future Treatment for Age-Related Macular Degeneration

A research team, led by BrightFocus Foundation Macular Degeneration Research grantee Daisy Yao Shu, PhD, studied inflammation of the retinal pigment epithelium, a layer of cells next to the retina that’s believed to be where age-related macular degeneration begins.

The team focused on the role of tumor necrosis factor-alpha (TNFα), a pro-inflammatory factor that may be related to the development and progression of age-related macular degeneration and treatment with an anti-inflammatory drug called dimethyl fumarate (DMFu).

Read more at www.brightfocus.org/ShuArticle.

#maculardegeneration #inflammation #scientificresearch #eyehealth #retina

Комментарии

Информация по комментариям в разработке